XBI Holdings Information

XBI is an equity ETF with a total of 153 individual holdings. The top holdings are Revolution Medicines stock at 1.76%, Travere Therapeutics at 1.72%, TG Therapeutics at 1.65%, Alkermes at 1.55%, and Arrowhead Pharmaceuticals at 1.55%.

Total Holdings

153

Top 10 Percentage

15.27%

Asset Class

Equity

ETF Category

Health

Assets

7.91B

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	1.76%	964,300
2	TVTX	Travere Therapeutics, Inc.	1.72%	3,245,862
3	TGTX	TG Therapeutics, Inc.	1.65%	3,423,939
4	ALKS	Alkermes plc	1.55%	3,458,617
5	ARWR	Arrowhead Pharmaceuticals, Inc.	1.55%	1,653,085
6	CYTK	Cytokinetics, Incorporated	1.44%	1,509,474
7	CELC	Celcuity Inc.	1.41%	829,679
8	EXEL	Exelixis, Inc.	1.40%	2,300,540
9	NBIX	Neurocrine Biosciences, Inc.	1.39%	741,383
10	MDGL	Madrigal Pharmaceuticals, Inc.	1.39%	222,592
11	KRYS	Krystal Biotech, Inc.	1.38%	376,677
12	TWST	Twist Bioscience Corporation	1.34%	2,049,737
13	PRAX	Praxis Precision Medicines, Inc.	1.32%	323,482
14	SRRK	Scholar Rock Holding Corporation	1.31%	2,224,444
15	ROIV	Roivant Sciences Ltd.	1.28%	3,247,321
16	APGE	Apogee Therapeutics, Inc.	1.27%	1,286,120
17	PTCT	PTC Therapeutics, Inc.	1.26%	1,462,635
18	IMVT	Immunovant, Inc.	1.26%	2,909,648
19	MIRM	Mirum Pharmaceuticals, Inc.	1.23%	1,046,786
20	PTGX	Protagonist Therapeutics, Inc.	1.22%	995,640
21	VCYT	Veracyte, Inc.	1.22%	2,219,420
22	NTRA	Natera, Inc.	1.22%	488,504
23	BEAM	Beam Therapeutics Inc.	1.21%	3,682,999
24	HALO	Halozyme Therapeutics, Inc.	1.21%	1,444,898
25	UTHR	United Therapeutics Corporation	1.21%	176,355

Showing 25 of 153 holdings

Subscribe to see the full list

Activate Now

As of May 20, 2026